Welcome to Scope the disability organization in England and Wales whose focus is people with Cerebral Palsy. Our aim is that disabled people achieve equality: a society in which they are as valued and have the same human and civil rights as everyone else. Scope's purpose is to drive the changes that will make our society the first in which disabled people are able to realise their full civil liberties and human rights.
New England Journal of Medicine abstract of study to evaluate the effects of induction of moderate hypothermia in infants who had perinatal asphyxia. Study concluded that Induction of moderate hypothermia for 72 hours in infants who had perinatal asphyxia did not significantly reduce the combined rate of death or severe disability but resulted in improved neurologic outcomes in survivors. (Current Controlled Trials number, ISRCTN89547571 [controlled-trials.com] .)
Article from The New England Journal of Medicne - offering information on a Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy. Published March 4 in the New England Journal of Medicine*, data from the double-blind, randomized, comparative clinical trial fill a large information gap in the treatment of childhood absence epilepsy, also known as "petit mal" epilepsy. The research, which identifies important differences between drugs in seizure control and side effects, is expected to impact how physicians select and monitor initial therapy for children with the disorder and ultimately lead to improved outcomes.